Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors ( quarterly report on Form 10-Q for the ...)

Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

quarterly report on Form 10-Q for the fiscal quarter ended March 30, 2007 and other filings with the Securities and Exchange Commission. Exelixis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

SOURCE Exelixis, Inc.

Investor Contact: Charles Butler, Director, Corporate Communications,

+1-650-837-7277, cbutler@exelixis.com, or

Media Contact: Hal Mackins, Corporate Communications,

+1-650-837-7012, hmackins@exelixis.com, both of Exelixis, Inc.

Web site: http://www.exelixis.com <http://www.exelixis.com/>

-------------

(Back to top)

Exelixis Reports Integrated Data From Phase II Clinical Trials of XL999 at ASCO

CHICAGO, June 3, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Exelixis, Inc. (Nasdaq: EXEL) reported integrated data from six Phase II clinical trials of XL999 in patients with non-small cell lung cancer (NSCLC), renal cell carcinoma, metastatic colorectal cancer, recurrent ovarian cancer, acute myelogenous leukemia (AML), and multiple myeloma. Results show preliminary anti-tumor activity in patients with NSCLC and AML, as well as a cardiovascular adverse event profile consistent with previously reported data. The data were presented in a poster session on Sunday, June 3, 2007 (Abstract #3591) at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO).

The primary objectives of each trial were to determine the response rate and to further evaluate the safety and tolerabilit
'"/>

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference

Post Your Comments:

(Date:5/23/2013)... May 23, 2013 More than half of ... benefit from chemotherapy and still have excellent outcomes. To ... one of the largest sources of online consumer information ... interactive Facebook page provide recently diagnosed women with information ... avoid chemotherapy. "We anticipate these innovative social ...

(Date:5/23/2013)... -- Texas, premier physician associations today announced the establishment of ... need to provide demonstrably better and more efficient patient ... "I am confident the Physician Services Organization for ... Stephen L. Brotherton , MD, president of the ... doctors are determined to make health care better and ...

(Date:5/23/2013)... -- Ameritox, the nation,s leader in pain medication monitoring, ... become part of its Urine Drug Monitoring (UDM) ... improve the clinical outcomes for injured workers. ... in the workers, compensation industry, has used UDM ... strategy for several years. By establishing a comprehensive ...

Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2 Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3 TMA Launches Physician Services Organization for Patient Care 2 TMA Launches Physician Services Organization for Patient Care 3 TMA Launches Physician Services Organization for Patient Care 4 Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2 Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3

[0] Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions [0] TMA Launches Physician Services Organization for Patient Care [0] Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers

... OmniComm Systems, Inc. (OTC Bulletin Board: OMCM ... announced that it will be hosting the autumn eClinical ... in Fort Lauderdale, Florida from November 03-05, 2010. The ... Life Science organizations. The informal ambiance provides support for ...

... Calif., Sept. 21 Bionovo, Inc. (Nasdaq: BNVI, BNVID), a ... in women,s health and oncology, today announced that Dr. Isaac ... at the JMP Securities Healthcare Conference at 4:00 p.m. ET ... at the New York Palace hotel in New York City. ...

Cached Medicine Technology:OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting 2 OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting 3 Bionovo to Present at the JMP Securities Healthcare Conference 2

OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting Bionovo to Present at the JMP Securities Healthcare Conference

(Date:5/24/2013)... HealthDay Reporter , , FRIDAY, May 24 (HealthDay ... are remarkable. But it was a physical challenge in ... of her sport. "I was an 11-year-old girl ... scoliosis was diagnosed by my orthopedic surgeon," said Lewis, ... Research Society and the American Academy of Orthopaedic Surgeons ...

(Date:5/24/2013)... 24, 2013 ResortQuest Real Estate® is ... Dayna Feher team at the firm’s Bethany Beach location. ... resorts her home in 1975. Her real estate career ... all aspects of the real estate business - receptionist, ... 12 years, a licensed sales associate. , “I ...

(Date:5/24/2013)... 24, 2013 The Mirena IUD lawyers ... news that the FDA has received more than 59,229 complaints ... from the intrauterine birth control device known as the Mirena ... issues reported by the women “included ‘expulsion,’ where the IUD ... that occurring,” according to an ABC News article. “Abdominal pain ...

(Date:5/24/2013)... CHI-California Healthcare Institute today submitted ... congressional delegation, joined by over 40 biomedical companies, ... paid to the U.S. Food and Drug Administration ... cuts will not include user fees paid to ... Development and FDA Appropriations Bill. CHI is a ...

(Date:5/24/2013)... Started in 1982, AMTC’s SHINE event is ... marks AMTC’s 31st anniversary. SHINE is a ministry run by ... Lewis and her daughter, Carey Lewis Arban. , This summer’s ... and music professionals including the New York Film Academy, The ... are kings of Hollywood and Christian casting directors. They seek ...

Breaking Medicine News(10 mins):Health News:Top-Ranked Golfer Beats Scoliosis 2 Health News:Top-Ranked Golfer Beats Scoliosis 3 Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2 Health News:Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes 2 Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2 Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3 Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2

[0] Top-Ranked Golfer Beats Scoliosis [0] Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team [0] Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes [0] California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 [0] AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013

... some states have cut breast cancer screening programs , TUESDAY, ... mammograms for women ages 40 to 49 has decreased since ... the U.S. Preventive Services Task Force, according to a new ... risk for breast cancer should start having mammograms every two ...

... at the Mayo Clinic campus in Florida have found ... lung cancers, is over-produced in pancreatic cancer and is ... genetically inhibiting PKC in laboratory animals led to a ... The discovery, reported in the March 1 issue of ...

... ... ... ... ...

... often think about hot flashes, hormone shifts and mood swings. ... of heart disease intensifies drastically around the time of natural menopause, ... This news may come as a surprise, but experts explain that ... that there are ways to lower your risk. ...

... ... at the Parallels Summit 2010 , ... Miami, FL (PRWEB) February 23, 2010 -- Worldwide cloud enablement leader, ... Parallels Summit 2010., , ,Highlighting excellence in the industry, the awards recognize the outstanding ...

... ... ... ... ...

Access to Mammograms Drops After Guidelines Change Mayo Clinic researchers find oncogene is important in pancreatic cancer growth and spread Monique da Silva Joins Ogilvy Public Relations Worldwide to Lead North America Healthcare Practice Changes during menopause increases risk of heart disease and stroke Winners are Grinners at the Inaugural Parallels Partner Awards Jiffy Lube(R) Well On Its Way to Raising Another $1 Million to Fight Heart Disease

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

Medicine Products:

Immunoglobulin G, CSF Index Immunoglobulin G Subclass 3 Immunoglobulin G Subclass 1 Immunoglobulin E